Rich Pharmaceuticals, Inc. (OTCPK:RCHA) announced that it has entered into securities purchase agreement for private placement of convertible promissory note for gross proceeds of $34,500 with returning investor GHS Investments, LLC on November 3, 2017. The note carries a coupon of 10% per annum and would mature on August 3, 2018. The note is being issued with a 10% original issuance discount and with an initial $1,500 being withheld by the company to offset transaction costs.

The company will issue securities pursuant to exemption under Regulation D.